Real-World Assessment of Systemic Disease Activity in Seropositive and Seronegative Patients with Sjögren’s Disease and Association with Patient-Reported Outcomes
Systemic disease activity and patient-reported symptomatology were significantly associated with health-related quality of life measures, highlighting the need for disease management that considers both clinical outcomes and the patient experience.
Authors
- Megan Hughes (ORCID: https://orcid.org/0000-0002-7188-3221)
- Angelina Villası́s-Keever (ORCID: https://orcid.org/0000-0002-8421-2195)
- Harman Dhatt
- Victoria Barton (ORCID: https://orcid.org/0009-0005-2636-0703)
- András Borsi (ORCID: https://orcid.org/0000-0003-4612-9830)
- U. Sbarigia (ORCID: https://orcid.org/0000-0003-3303-2554)
- Wim Noël (ORCID: https://orcid.org/0000-0002-5988-4627)
- Nicola Massey (ORCID: https://orcid.org/0000-0002-5626-3163)
- Raphaèle Séror (ORCID: https://orcid.org/0000-0002-5523-1856)
- Federico Zazzetti
- Sarah Weatherby (ORCID: https://orcid.org/0009-0009-6750-2666)
- Jacques‐Eric Gottenberg (ORCID: https://orcid.org/0000-0002-9469-946X)
- Anna Sheahan
Institutions
- Centre National de la Recherche Scientifique (FR)
- Johnson & Johnson (United States) (US)
- Adelphi Group (United Kingdom) (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpitaux Universitaires Paris-Ouest (FR)
- Université de Strasbourg (FR)
Publication Details
- Journal
- Rheumatology and Therapy
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1007/s40744-025-00792-4
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 0.00